Direct Transarterial Embolization with n-Butyl-2-Cyanoacrylate Should be the Choice of Treatment for Spontaneous Hematomas in Patients on Anticoagulation Treatment

dc.contributor.authorOzyer, Umut
dc.contributor.orcID0000-0002-4300-009Xen_US
dc.contributor.pubmedID28698993en_US
dc.contributor.researcherIDAAK-9071-2021en_US
dc.date.accessioned2023-08-11T08:27:12Z
dc.date.available2023-08-11T08:27:12Z
dc.date.issued2017
dc.identifier.eissn1432-086Xen_US
dc.identifier.endpage1650en_US
dc.identifier.issn0174-1551en_US
dc.identifier.issue10en_US
dc.identifier.scopus2-s2.0-85023193196en_US
dc.identifier.startpage1649en_US
dc.identifier.urihttp://hdl.handle.net/11727/10245
dc.identifier.volume40en_US
dc.identifier.wos000409109400022en_US
dc.language.isoengen_US
dc.relation.isversionof10.1007/s00270-017-1742-xen_US
dc.relation.journalCARDIOVASCULAR AND INTERVENTIONAL RADIOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectTRANSCATHETER ARTERIAL EMBOLIZATIONen_US
dc.subjectMANAGEMENTen_US
dc.titleDirect Transarterial Embolization with n-Butyl-2-Cyanoacrylate Should be the Choice of Treatment for Spontaneous Hematomas in Patients on Anticoagulation Treatmenten_US
dc.typeLetteren_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: